Last reviewed · How we verify

NCT06960655

Improving Lipid Optimization Quality and Treatment Options in ASCVD

ENROLLING BY INVITATION NA Last updated 6 February 2026
What this trial tests

NA trial testing Referral to Pharmacist-Driven Medication Management Program in Hypercholesterolemia in 300 participants. Enrolling by invitation.

Timeline
14 October 2025
Primary endpoint
1 April 2026
1 November 2026

Quick facts

Lead sponsorBrigham and Women's Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment300
Start date14 October 2025
Primary completion1 April 2026
Estimated completion1 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 95, any sex, with Hypercholesterolemia or ASCVD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this project is to study different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholesterol buildup in the arteries).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypercholesterolemia

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06960655.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing